# BeOne Medicines Ltd.: filings

ONC · Nasdaq · CIK 1651308 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/onc.md) · [Financials](/companies/onc/financials.md) · [Filings](/companies/onc/filings.md) · [Insiders](/companies/onc/insiders.md)

## Reports and events: 374 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 520, 8-K 283, 144 140, 3 37, 10-Q 32, CORRESP 28, UPLOAD 23, SC 13G/A 18, SC 13D/A 17, DEF 14A 13, 10-K 11, PRE 14A 11, S-8 10, S-8 POS 9, 424B5 8, S-3ASR 8, EFFECT 6, S-1/A 6, SC 13G 6, DEFA14A 5, SCHEDULE 13D/A 5, ARS 4, CT ORDER 4, 4/A 3, POSASR 3, 10-K/A 2, 3/A 2, 424B4 2, 424B7 2, 5 2, FWP 2, S-1 2, S-1MEF 2, S-4/A 2, SC 13D 2, SCHEDULE 13G/A 2, 144/A 1, 424B2 1, 424B3 1, 8-A12B 1, 8-K12G3 1, 8-K/A 1, CERTNAS 1, DRS 1, DRS/A 1, POS AM 1, PRER14A 1, S-4 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-16 | 16:24 ET | [SCHEDULE 13D/A](/filings/0001104659-26-108269.md) | Ownership report, active investor, amended | 0001104659-26-108269 |
| 2026-08-26 | 06:14 ET | [8-K](/filings/0001651308-26-000025.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001651308-26-000025 |
| 2026-08-05 | 06:04 ET | [10-Q](/filings/0001628280-26-052878.md) | Quarterly report, period 2026-06-30 | 0001628280-26-052878 |
| 2026-08-05 | 06:02 ET | [8-K](/filings/0001628280-26-052877.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-052877 |
| 2026-06-26 | 06:02 ET | [8-K](/filings/0001651308-26-000020.md) | 8.01 Other events | 0001651308-26-000020 |
| 2026-06-15 | 16:40 ET | [SCHEDULE 13D/A](/filings/0001104659-26-074089.md) | Ownership report, active investor, amended | 0001104659-26-074089 |
| 2026-06-11 | 16:13 ET | [8-K](/filings/0001651308-26-000017.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001651308-26-000017 |
| 2026-05-15 | 16:08 ET | [8-K](/filings/0001651308-26-000012.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001651308-26-000012 |
| 2026-05-06 | 06:05 ET | [10-Q](/filings/0001628280-26-030867.md) | Quarterly report, period 2026-03-31 | 0001628280-26-030867 |
| 2026-05-06 | 06:03 ET | [8-K](/filings/0001628280-26-030866.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-030866 |
| 2026-04-28 | 06:01 ET | [DEF 14A](/filings/0001104659-26-049655.md) | Proxy statement, period 2026-06-11 | 0001104659-26-049655 |
| 2026-04-16 | 16:32 ET | [SCHEDULE 13D/A](/filings/0001104659-26-044411.md) | Ownership report, active investor, amended | 0001104659-26-044411 |
| 2026-04-14 | 09:49 ET | [8-K](/filings/0001651308-26-000008.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001651308-26-000008 |
| 2026-02-26 | 06:09 ET | [10-K](/filings/0001628280-26-011946.md) | Annual report, period 2025-12-31 | 0001628280-26-011946 |
| 2026-02-26 | 06:04 ET | [8-K](/filings/0001628280-26-011941.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-011941 |
| 2025-12-19 | 06:01 ET | [8-K](/filings/0001651308-25-000153.md) | 1.02 Termination of a material agreement | 0001651308-25-000153 |
| 2025-12-18 | 06:02 ET | [8-K](/filings/0001651308-25-000151.md) | 5.02 Departure or appointment of officers or directors | 0001651308-25-000151 |
| 2025-11-19 | 06:02 ET | [8-K](/filings/0001651308-25-000148.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001651308-25-000148 |
| 2025-11-06 | 06:07 ET | [10-Q](/filings/0001628280-25-049824.md) | Quarterly report, period 2025-09-30 | 0001628280-25-049824 |
| 2025-11-06 | 06:03 ET | [8-K](/filings/0001628280-25-049821.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-049821 |
| 2025-08-29 | 06:52 ET | [8-K](/filings/0001651308-25-000136.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001651308-25-000136 |
| 2025-08-25 | 06:24 ET | [8-K](/filings/0001628280-25-041082.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-041082 |
| 2025-08-06 | 06:05 ET | [10-Q](/filings/0001651308-25-000133.md) | Quarterly report, period 2025-06-30 | 0001651308-25-000133 |
| 2025-08-06 | 06:02 ET | [8-K](/filings/0001651308-25-000131.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001651308-25-000131 |
| 2025-05-21 | 16:45 ET | [8-K](/filings/0001651308-25-000084.md) | 5.07 Shareholder vote results | 0001651308-25-000084 |
| 2025-05-13 | 16:15 ET | [SCHEDULE 13D/A](/filings/0000902664-25-002297.md) | Ownership report, active investor, amended | 0000902664-25-002297 |
| 2025-05-13 | 16:03 ET | [8-K](/filings/0001651308-25-000078.md) | 3.02 Unregistered sale of equity | 0001651308-25-000078 |
| 2025-05-07 | 06:09 ET | [10-Q](/filings/0001651308-25-000075.md) | Quarterly report, period 2025-03-31 | 0001651308-25-000075 |
| 2025-05-07 | 06:04 ET | [8-K](/filings/0001651308-25-000074.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001651308-25-000074 |
| 2025-04-29 | 17:03 ET | [8-K](/filings/0001651308-25-000066.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001651308-25-000066 |
| 2025-04-28 | 16:09 ET | [8-K](/filings/0001651308-25-000063.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001651308-25-000063 |
| 2025-04-28 | 08:26 ET | [8-K](/filings/0001651308-25-000057.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001651308-25-000057 |
| 2025-04-07 | 06:03 ET | [DEF 14A](/filings/0001104659-25-032346.md) | Proxy statement, period 2025-05-21 | 0001104659-25-032346 |
| 2025-03-03 | 21:30 ET | [SCHEDULE 13D/A](/filings/0000902664-25-001327.md) | Ownership report, active investor, amended | 0000902664-25-001327 |
| 2025-02-28 | 16:05 ET | [10-K/A](/filings/0001651308-25-000036.md) | Annual report, amended, period 2024-12-31 | 0001651308-25-000036 |
| 2025-02-27 | 06:12 ET | [10-K](/filings/0001651308-25-000031.md) | Annual report, period 2024-12-31 | 0001651308-25-000031 |
| 2025-02-27 | 06:04 ET | [8-K](/filings/0001651308-25-000029.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001651308-25-000029 |
| 2025-01-13 | 17:02 ET | [8-K](/filings/0001651308-25-000012.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001651308-25-000012 |
| 2025-01-08 | 06:02 ET | [10-K/A](/filings/0001651308-25-000005.md) | Annual report, amended, period 2023-12-31 | 0001651308-25-000005 |
| 2024-12-23 | 06:05 ET | [8-K](/filings/0001651308-24-000171.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001651308-24-000171 |
| 2024-12-10 | 21:30 ET | [SC 13D/A](/filings/0001104659-24-127397.md) | Ownership report, active investor, amended | 0001104659-24-127397 |
| 2024-12-10 | 06:02 ET | [8-K](/filings/0001651308-24-000164.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001651308-24-000164 |
| 2024-12-04 | 16:05 ET | [SC 13D/A](/filings/0000902664-24-006827.md) | Ownership report, active investor, amended | 0000902664-24-006827 |
| 2024-11-19 | 06:03 ET | [8-K](/filings/0001651308-24-000157.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001651308-24-000157 |
| 2024-11-14 | 06:05 ET | [8-K](/filings/0001651308-24-000154.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001651308-24-000154 |
| 2024-11-12 | 06:06 ET | [10-Q](/filings/0001651308-24-000152.md) | Quarterly report, period 2024-09-30 | 0001651308-24-000152 |
| 2024-11-12 | 06:03 ET | [8-K](/filings/0001651308-24-000150.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001651308-24-000150 |
| 2024-10-28 | 06:05 ET | [8-K](/filings/0001651308-24-000139.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001651308-24-000139 |
| 2024-09-30 | 06:02 ET | [8-K](/filings/0001651308-24-000123.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001651308-24-000123 |
| 2024-09-26 | 06:12 ET | [8-K](/filings/0001651308-24-000118.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001651308-24-000118 |

Page 1 of 8. [Older](/companies/onc/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 17:05 ET. No prices; not investment advice.